Volume 17, Issue 1

PharmacoEconomics & Outcomes News is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all PharmacoEconomics & Outcomes News articles

November 1994

33 articles in this issue

Pharmacoeconomics is evolving, but still nonstandardised

Comment 16 February 2013 Pages: 2 - 2
UK government's response to healthcare recommendations

Comment 16 February 2013 Pages: 2 - 2
Outcomes research – sorting out what works in medicine

Comment 16 February 2013 Pages: 3 - 4
Metoprolol proven beneficial in MI . . .

Review 16 February 2013 Pages: 4 - 4
No clinical basis for OTC H2-antagonists

Correspondence 16 February 2013 Pages: 4 - 4
The financial impact of schizophrenia

Clinical study 16 February 2013 Pages: 5 - 5
Use a proactive focus for formulary systems

Comment 16 February 2013 Pages: 5 - 5
H. influenzae cost-benefit analyses need to be country-specific

Review 16 February 2013 Pages: 6 - 6
The benefits associated with primary care

Comment 16 February 2013 Pages: 6 - 6
Educate to optimise the use of drugs in surgery

Clinical study 16 February 2013 Pages: 7 - 7
Is tacrolimus more cost effective than cyclosporin?

News item 16 February 2013 Pages: 7 - 7
Team approach lowers costs of geriatric care

Non-clinical study 16 February 2013 Pages: 7 - 7
`Community pharmacists provide a considerable cost effective contribution to the National Health Service',

Non-clinical study 16 February 2013 Pages: 8 - 8
Assessing the cost of congenital heart disease

Clinical study 16 February 2013 Pages: 8 - 8
Cheaper therapy for postoperative nausea and vomiting.

Clinical study 16 February 2013 Pages: 8 - 8
Cost savings from reduced demand for epoetin

Clinical study 16 February 2013 Pages: 8 - 8
Hib vaccine cost beneficial in children

Clinical study 16 February 2013 Pages: 9 - 9
Justifying the use of vecuronium bromide reduces costs

Non-clinical study 16 February 2013 Pages: 9 - 9
Hospital charges reduced by interleukin 1α

Animal 16 February 2013 Pages: 10 - 10
Interferon-α2A cost effective in chronic hepatitis B

Clinical study 16 February 2013 Pages: 10 - 10
A unique IV-to-oral conversion programme

Comment 16 February 2013 Pages: 11 - 11
Switch from IV to oral famotidine and save

Clinical study 16 February 2013 Pages: 11 - 11
Superior results with floxuridine for liver metastases

Clinical study 16 February 2013 Pages: 12 - 12
The importance of specialty care in improving QOL post-MI

Clinical study 16 February 2013 Pages: 12 - 12
Accurately forecasting hospital drug expenditures

Non-clinical study 16 February 2013 Pages: 13 - 13
Linking drug therapy improvement and prescriber credentialing

Non-clinical study 16 February 2013 Pages: 13 - 13
Your questions answered

Comment 16 February 2013 Pages: 14 - 14
Did you know . . . ?

Clinical study 16 February 2013 Pages: 15 - 15
UK public does not support more prescription-to-OTC switches

Comment 16 February 2013 Pages: 15 - 15
US drug prices show lowest increase for 20 years.

Comment 16 February 2013 Pages: 15 - 15
GP fundholding schemes expanding in the UK.

Comment 16 February 2013 Pages: 16 - 16
Rate of therapeutic substitution slows in the US.

Comment 16 February 2013 Pages: 16 - 16
Widening price gaps reported in Japan.

Comment 16 February 2013 Pages: 16 - 16

Volume 17, Issue 1

Search

Navigation